Mesothelin SS-(dsFv)-PE38

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMesothelin SS-(dsFv)-PE38
Drug Alias NameMesothelium Antigen TherapyMesothelin MabSS(dsFv) PE38SS1-PE38
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell Lung +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteNeopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeopharmNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell Lung +[11] 

Other Information

ATC CodeN/A
Related LinksN/A